EUS Evaluation of Perianal and Peri-rectal Fistulizing Crohn's Disease With CERTOLIZUMAB Treatment
Status:
Terminated
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess perianal and perirectal fistula healing
(complete closure) based on endoscopic ultrasound (EUS) evaluation at 3 months and by PDAI
(Pouchitis Disease Activity Index) and Fistula Drainage assessment by 6 months, showing no
fistula (new or recurrence) in treatment of Crohn's' disease patient with Certolizumab
(Cimzia).